Medicinal Product Regulation and Product Liability in South Africa
Medicinal product regulation and product liability in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to medicinal product regulation and product liability law in South Africa.
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
To read the full Q&A, visit Thomsan Reuters Practical Law.
For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Pharmaceutical IP and Competition Law in South Africa: overview.
New South African national research facility for local manufacturing of pharmaceuticals
A new national research facility of South Africa’s Council for Scientific and Industrial Research (CSIR) was officially opened on 7 October 2026. Known as FuturePHARMA, the facility forms part of th...
November 18 2026
Wits University seeks closer cooperation with WIPO
The Director General of the World Intellectual Property Organization (WIPO), Daren Tang, recently met with Professor Zeblon Vilakazi, the Vice-Chancellor and Principal of South Africa’s University o...
November 18 2026
Highlights of the Adams & Adams Africa Network Meeting
The 13th Adams & Adams Africa Network Meeting brought together more than 80 IP professionals and stakeholders from 25 countries under the theme ‘Playing to Win: Building Advantage Through IP’....
November 18 2026

